163 related articles for article (PubMed ID: 20044804)
1. Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma.
Reschke M; Ferby I; Stepniak E; Seitzer N; Horst D; Wagner EF; Ullrich A
Hepatology; 2010 Apr; 51(4):1383-90. PubMed ID: 20044804
[TBL] [Abstract][Full Text] [Related]
2. Evidence that MIG-6 is a tumor-suppressor gene.
Zhang YW; Staal B; Su Y; Swiatek P; Zhao P; Cao B; Resau J; Sigler R; Bronson R; Vande Woude GF
Oncogene; 2007 Jan; 26(2):269-76. PubMed ID: 16819504
[TBL] [Abstract][Full Text] [Related]
3. Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-κB activity.
Lin CI; Barletta JA; Nehs MA; Morris ZS; Donner DB; Whang EE; Jeong JW; Kimura S; Moore FD; Ruan DT
Surgery; 2011 Dec; 150(6):1295-302. PubMed ID: 22136853
[TBL] [Abstract][Full Text] [Related]
4. Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation.
Ferby I; Reschke M; Kudlacek O; Knyazev P; Pantè G; Amann K; Sommergruber W; Kraut N; Ullrich A; Fässler R; Klein R
Nat Med; 2006 May; 12(5):568-73. PubMed ID: 16648858
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer.
Lin CI; Du J; Shen WT; Whang EE; Donner DB; Griff N; He F; Moore FD; Clark OH; Ruan DT
J Clin Endocrinol Metab; 2011 Mar; 96(3):E554-65. PubMed ID: 21190978
[TBL] [Abstract][Full Text] [Related]
6. Mitogen-Inducible Gene-6 Mediates Feedback Inhibition from Mutated BRAF towards the Epidermal Growth Factor Receptor and Thereby Limits Malignant Transformation.
Milewska M; Romano D; Herrero A; Guerriero ML; Birtwistle M; Quehenberger F; Hatzl S; Kholodenko BN; Segatto O; Kolch W; Zebisch A
PLoS One; 2015; 10(6):e0129859. PubMed ID: 26065894
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-374a Promotes Hepatocellular Carcinoma Cell Proliferation by Targeting Mitogen-Inducible Gene 6 (MIG-6).
Li H; Chen H; Wang H; Dong Y; Yin M; Zhang L; Wei J
Oncol Res; 2018 May; 26(4):557-563. PubMed ID: 28734040
[TBL] [Abstract][Full Text] [Related]
8. Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasis.
Jin N; Cho SN; Raso MG; Wistuba I; Smith Y; Yang Y; Kurie JM; Yen R; Evans CM; Ludwig T; Jeong JW; DeMayo FJ
Development; 2009 Oct; 136(19):3347-56. PubMed ID: 19710174
[TBL] [Abstract][Full Text] [Related]
9. Mig-6 overcomes gefitinib resistance by inhibiting EGFR/ERK pathway in non-small cell lung cancer cell lines.
Li ZX; Qu LY; Wen H; Zhong HS; Xu K; Qiu XS; Wang EH
Int J Clin Exp Pathol; 2014; 7(10):7304-11. PubMed ID: 25400829
[TBL] [Abstract][Full Text] [Related]
10. CKAP4 inhibited growth and metastasis of hepatocellular carcinoma through regulating EGFR signaling.
Li SX; Liu LJ; Dong LW; Shi HG; Pan YF; Tan YX; Zhang J; Zhang B; Ding ZW; Jiang TY; Hu HP; Wang HY
Tumour Biol; 2014 Aug; 35(8):7999-8005. PubMed ID: 24838946
[TBL] [Abstract][Full Text] [Related]
11. Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma.
Kang DH; Jung SS; Yeo MK; Lee DH; Yoo G; Cho SY; Oh IJ; Kim JO; Park HS; Chung C; Lee JE
BMC Cancer; 2020 Jun; 20(1):571. PubMed ID: 32552717
[TBL] [Abstract][Full Text] [Related]
12. Mig-6 controls EGFR trafficking and suppresses gliomagenesis.
Ying H; Zheng H; Scott K; Wiedemeyer R; Yan H; Lim C; Huang J; Dhakal S; Ivanova E; Xiao Y; Zhang H; Hu J; Stommel JM; Lee MA; Chen AJ; Paik JH; Segatto O; Brennan C; Elferink LA; Wang YA; Chin L; DePinho RA
Proc Natl Acad Sci U S A; 2010 Apr; 107(15):6912-7. PubMed ID: 20351267
[TBL] [Abstract][Full Text] [Related]
13. The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment.
Huang P; Xu X; Wang L; Zhu B; Wang X; Xia J
J Cell Mol Med; 2014 Feb; 18(2):218-30. PubMed ID: 24268047
[TBL] [Abstract][Full Text] [Related]
14. Insulin receptor tyrosine kinase substrate activates EGFR/ERK signalling pathway and promotes cell proliferation of hepatocellular carcinoma.
Wang YP; Huang LY; Sun WM; Zhang ZZ; Fang JZ; Wei BF; Wu BH; Han ZG
Cancer Lett; 2013 Aug; 337(1):96-106. PubMed ID: 23693078
[TBL] [Abstract][Full Text] [Related]
15. Mutation of epidermal growth factor receptor is associated with MIG6 expression.
Nagashima T; Ushikoshi-Nakayama R; Suenaga A; Ide K; Yumoto N; Naruo Y; Takahashi K; Saeki Y; Taiji M; Tanaka H; Tsai SF; Hatakeyama M
FEBS J; 2009 Sep; 276(18):5239-51. PubMed ID: 19674104
[TBL] [Abstract][Full Text] [Related]
16. Leukocyte-specific protein 1: a novel regulator of hepatocellular proliferation and migration deleted in human hepatocellular carcinoma.
Koral K; Paranjpe S; Bowen WC; Mars W; Luo J; Michalopoulos GK
Hepatology; 2015 Feb; 61(2):537-47. PubMed ID: 25234543
[TBL] [Abstract][Full Text] [Related]
17. Low expression of Mig-6 is associated with poor survival outcome in NSCLC and inhibits cell apoptosis via ERK-mediated upregulation of Bcl-2.
Li Z; Qu L; Zhong H; Xu K; Qiu X; Wang E
Oncol Rep; 2014 Apr; 31(4):1707-14. PubMed ID: 24573418
[TBL] [Abstract][Full Text] [Related]
18. Gene 33 is an endogenous inhibitor of epidermal growth factor (EGF) receptor signaling and mediates dexamethasone-induced suppression of EGF function.
Xu D; Makkinje A; Kyriakis JM
J Biol Chem; 2005 Jan; 280(4):2924-33. PubMed ID: 15556944
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Cdc42 is essential for Mig-6 suppression of cell migration induced by EGF.
Jiang X; Niu M; Chen D; Chen J; Cao Y; Li X; Ying H; Bergholz J; Zhang Y; Xiao ZX
Oncotarget; 2016 Aug; 7(31):49180-49193. PubMed ID: 27341132
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of Mig-6 in nonsmall-cell lung cancer is associated with EGFR signaling.
Li Z; Dong Q; Wang Y; Qu L; Qiu X; Wang E
Mol Carcinog; 2012 Jul; 51(7):522-34. PubMed ID: 21739478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
